Summary
Viking Therapeutics Inc (Viking Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients suffering from metabolic and endocrine disorders. Its lead product candidate, VK5211, is an oral, a non-steroidal selective androgen receptor modulator (SARM) developed for the treating patients recovering from non-elective hip fracture surgery and is in phase II clinical trials. Viking Therapeutics’ other pipeline product candidates include VK0214 and VK2809 developed for adrenoleukodystrophy; and VK0612 for type 2 diabetes. The company also develops preclinical programs for other indications such as hypercholesterolemia and non-alcoholic steatohepatitis, metabolic diseases and anemia.Viking Therapeutics is headquartered in San Diego, California, the US.
Viking Therapeutics Inc (VKTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Viking Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Viking Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Viking Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Viking Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Viking Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Viking Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Viking Therapeutics Raises USD2.5 Million in Venture Financing 10
Partnerships 11
Kennedy Krieger Institute Enters into Research Agreement with Viking Therapeutics 11
Viking Therapeutics Enters into Research Agreement with Academic Medical Center 12
Licensing Agreements 13
Viking Therapeutics Amends Licensing Agreement with Ligand Pharma 13
Equity Offering 15
Viking Therapeutics Raises USD0.5 Million in First Tranche of Private Placement of Shares 15
Viking Therapeutics Plans to Raise Funds through Public Offering of Shares 17
Viking Therapeutics Completes Underwriter’s Exercise of Over-Allotment Option of Public Offering of Shares and Warrants for USD10.8 Million 18
Viking Therapeutics Completes Exercise of Underwriter's Over Allotment Option for IPO of Shares for USD27.6 Million 20
Viking Therapeutics Inc - Key Competitors 22
Key Employees 23
Locations And Subsidiaries 24
Head Office 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25
List of Tables
Viking Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Viking Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Viking Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Viking Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Viking Therapeutics Inc, Deals By Therapy Area, 2010 to YTD 2016 8
Viking Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Viking Therapeutics Raises USD2.5 Million in Venture Financing 10
Kennedy Krieger Institute Enters into Research Agreement with Viking Therapeutics 11
Viking Therapeutics Enters into Research Agreement with Academic Medical Center 12
Viking Therapeutics Amends Licensing Agreement with Ligand Pharma 13
Viking Therapeutics Raises USD0.5 Million in First Tranche of Private Placement of Shares 15
Viking Therapeutics Plans to Raise Funds through Public Offering of Shares 17
Viking Therapeutics Completes Underwriter’s Exercise of Over-Allotment Option of Public Offering of Shares and Warrants for USD10.8 Million 18
Viking Therapeutics Completes Exercise of Underwriter's Over Allotment Option for IPO of Shares for USD27.6 Million 20
Viking Therapeutics Inc, Key Competitors 22
Viking Therapeutics Inc, Key Employees 23
List of Figures
Viking Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Viking Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Viking Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Viking Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Viking Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Viking Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Viking Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Viking Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8